Lemaitre Vascular (LMAT) Net Income towards Common Stockholders (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Net Income towards Common Stockholders data on file, last reported at $15.7 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 42.39% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $64.7 million, a 11.58% increase from a year earlier, with the FY2025 full-year figure at $60.0 million, up 5.58% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $15.7 million, down from $17.9 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for LMAT reached as high as $24.0 million in Q4 2024 and fell as low as $3.5 million in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged $10.7 million across 5 years, with a median of $9.9 million in 2024.
• Across the five-year window, Net Income towards Common Stockholders plunged 57.65% in 2022 and jumped 183.77% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $4.4 million in 2022, then jumped by 91.91% to $8.5 million in 2023, then soared by 183.77% to $24.0 million in 2024, then retreated by 25.51% to $17.9 million in 2025, then dropped by 12.38% to $15.7 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $15.7 million in Q1 2026, $17.9 million in Q4 2025, and $17.4 million in Q3 2025.